1.30
Precedente Chiudi:
$1.37
Aprire:
$1.37
Volume 24 ore:
136.79K
Relative Volume:
0.04
Capitalizzazione di mercato:
$5.90M
Reddito:
$25.56M
Utile/perdita netta:
$2.47M
Rapporto P/E:
0.6187
EPS:
2.1013
Flusso di cassa netto:
$-1.53M
1 W Prestazione:
-12.00%
1M Prestazione:
-25.42%
6M Prestazione:
-96.89%
1 anno Prestazione:
-97.69%
Bon Natural Life Ltd Stock (BON) Company Profile
Nome
Bon Natural Life Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BON con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
BON
Bon Natural Life Ltd
|
1.3001 | 5.90M | 25.56M | 2.47M | -1.53M | 2.1013 |
![]()
LIN
Linde plc Ordinary Share
|
465.34 | 223.86B | 33.02B | 6.61B | 4.91B | 13.77 |
![]()
SHW
Sherwin Williams Co
|
347.22 | 90.40B | 23.04B | 2.68B | 2.18B | 10.58 |
![]()
ECL
Ecolab Inc
|
265.53 | 75.96B | 15.68B | 2.10B | 1.50B | 7.36 |
![]()
APD
Air Products Chemicals Inc
|
283.66 | 62.80B | 12.02B | 1.53B | -4.33B | 6.88 |
![]()
DD
Dupont De Nemours Inc
|
69.56 | 29.36B | 12.52B | -75.00M | 1.27B | -0.19 |
Bon Natural Life Ltd Borsa (BON) Ultime notizie
Metric Analysis: Bon Natural Life Ltd (BON)’s Key Ratios in the Limelight - DWinneX
Bon Natural Life enter distribution agreement with Tianjin Merrill-Youli Trading - MSN
Bon Natural Life Announces Distribution Agreement With Tianjin Merrill-Youli Trading Co - MarketScreener
Bon Natural Life Secures Major Distribution Deal with Merrill-Youli - TipRanks
Bon Natural Life signs $18 million fragrance distribution deal - Investing.com
Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd. - GlobeNewswire
Bon Natural Life Lands $18M Fragrance Deal and Unveils Game-Changing Biosynthetic Breakthrough - Stock Titan
Certain Class A Ordinary Shares of Bon Natural Life Limited are subject to a Lock-Up Agreement Ending on 16-JUN-2025. - marketscreener.com
Bon Natural Life Ltd (NASDAQ:BON) Short Interest Up 116.6% in May - Defense World
Bon Natural Life (NYSE:BON) Shares Down 4.8% – What’s Next? - Defense World
Bon Natural Life (NASDAQ:BON) Downgraded by Wall Street Zen to Sell - Defense World
Bon Natural Life Retail Buzz Builds As Stock Remains On Track To Extend Buyback Inspired Gains By Stocktwits - Investing.com India
Bon Natural Life announces share repurchase program for up to $1M - TipRanks
Bon Natural Life initiates $1 million share buyback - Investing.com Australia
Bon Natural Life Limited Announces $1.0 Million Share Repurchase Program - Nasdaq
BON Natural Life Board Approves $1M Stock Repurchase Plan: Key Details Investors Should Know - Stock Titan
Bon Natural Life (NASDAQ:BON) Stock Rating Upgraded by Wall Street Zen - Defense World
Bon Natural Life Limited Announces Cooperation Agreement Signed with Shanghai Risesun International Trade - marketscreener.com
Bon Natural Life Secures $24 Million Tea Pigment Deal with Shanghai Risesun - TipRanks
Bon Natural Life’s Tea Pigment Triumph: A Digestive Health Deal Brewing Big Gains! - RagingBull
BON Announces Launch of Tea Pigment Digestive Health - GlobeNewswire
Bon Natural Life announces sales cooperation agreement with Shanghai Risesun - TipRanks
BON Targets $1B Market With Breakthrough Tea Pigment Digestive Health Innovation - Stock Titan
Bon Natural Life (NYSE:BON) Trading Up 16.9% – Should You Buy? - Defense World
Bon Natural Life secures exclusive $32 million ingredient deal By Investing.com - Investing.com Nigeria
Bon Natural Life Limited Announces an Exclusive Cooperation Agreement with Beijing Huahai Keyuan Co., Ltd - marketscreener.com
Bon Natural Launches Postbiotic Hypoglycemic Product Line, Signs $32 Mln Distribution Agreement - Nasdaq
Bon Natural Life secures exclusive $32 million ingredient deal - Investing.com
Bon Natural Life Signs $32 Million Cooperation Agreement With Beijing Huahai Keyuan - marketscreener.com
Bon Natural Life’s Subsidiary Secures Exclusive Sales Partnership with Beijing Huahai Keyuan - TipRanks
BON Announces The Launch Of Its Postbiotic Hypoglycemic - GlobeNewswire
BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement - TradingView
BON Lands Exclusive $32M Partnership to Target $30B Blood Sugar Control Market with Patented Technology - Stock Titan
Bon Natural Life Announces Effectiveness Of Reverse Stock Split - marketscreener.com
Bon Natural Life Limited Announces 1-for-25 Reverse Stock Split to Comply with Nasdaq Listing Requirements - Nasdaq
Bon Natural Life's 25:1 Reverse Split Aims to Save Nasdaq ListingKey Changes Coming May 19 - Stock Titan
Nasdaq-listed Bon Natural Life launches broccoli-derived sleep supplement line - Mugglehead Magazine
BON Natural Life launches new sleep health products By Investing.com - Investing.com India
BON Natural Life launches new sleep health products - Investing.com Australia
BON Natural Life Limited Unveils Innovative Sleep Health Product Series Utilizing Patent-Pending Glucoraphanin-Myrosinase Delivery System - Nasdaq
BON Debuts Groundbreaking Broccoli-Derived Sleep Wellness Line, Reshaping the Sleep Health Market through Innovative Technology - Stock Titan
US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert - Benzinga
BONBon Natural Life Ltd Latest Stock News & Market Updates - Stock Titan
Bon Natural faces Nasdaq delisting over share price woes - Investing.com Australia
Offerings News Live Feed - Stock Titan
Bon Natural faces Nasdaq delisting over share price woes By Investing.com - Investing.com South Africa
Bon Natural Life Limited Announces Receipt Of Nasdaq Delisting Notifications - TradingView
Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications - The Manila Times
Bon Natural Life Limited Receives Nasdaq Delisting Notification and Appeals Decision - Nasdaq
Bon Natural Life Receives Double Delisting Notice as Stock Crashes Below 10 Cents - Stock Titan
META_TITLE_SECTORS - Yahoo Finance
Bon Natural Life Ltd Azioni (BON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):